IP Library Granted Patent US 9,949,918
Granted Patent B2
US 9,949,918 · App. 14/361,701 · Granted Apr 24, 2018

Jojoba extract useful in improving skin barrier functions

Inventors: Etienne Soudant (Paris, FR); Ilana Kachko-Chernetsky (Rehovot, IL); Fabien Havas (Rehovot, IL); Olga Ben-Chitrit (Ashdod, IL); Lea Von Oppen-Bezalel (Berlin, DE); Inon Perry (Tel Aviv, IL); Alex Aliluiko (Rehovot, IL)
Assignee: IBR—Israeli Biotechnology Research Ltd.
A61K8/97A61K36/185A61Q17/00A61Q19/08A61Q19/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,949,918
App. No.
14/361,701
Granted
Apr 24, 2018
Kind
B2
Abstract

The present invention provides compositions comprising extracts of Jojoba ( Simmondsia chinensis ) in a polar solvent that are effective in promoting the barrier functions of the skin, useful for improving skin integrity, health and appearance and as anti-aging agent.

Claims (29)

1. A method for maintaining and/or promoting skin structure, strength, cohesion or any combination thereof comprising administering to the skin of a subject in need thereof a composition comprising as an active ingredient a polar solvent extract of raw Jojoba ( Simmondsia chinensis ) plant or part thereof,

wherein the extract is produced by a method comprising the steps of:

a. mixing a raw Jojoba plant or any part thereof with at least one polar solvent;

b. incubating the mixture for a time period sufficient to form a liquid extract wherein the incubation temperature is in the range of 20° C-120° C.;

c. removing the Jojoba plant or parts thereof and collecting the liquid extract;

d. filtering the liquid extract; and

e. collecting the filtrate;

wherein the extract is effective in promoting cell to cell adhesion in said skin;

thereby promoting cell to cell adhesion and maintaining and/or promoting the skin structure, strength, cohesion or any combination thereof and maintaining or promoting the skin barrier function.

2. The method of claim 1 , wherein maintaining or promoting the skin barrier function comprises at least one of maintaining or reducing the skin dehydration rate; maintaining or promoting the skin hydration value; maintaining or promoting protection from environmental hazards and any combination thereof.

3. The method of claim 1 , wherein said method is effective in at least one of maintaining or improving the skin health, skin integrity, skin firmness, skin extensibility, skin elasticity, overall skin appearance and any combination thereof.

4. The method of claim 3 , wherein improving the skin health comprises at least one of relieving the symptoms of eczema, dermatoses, psoriasis vulgaris, lichen planus, ichthyosis, ichthyosis vulgaris and cholangitis; preventing blistering disorders; maintaining normal skin homeostasis; facilitating skin wound healing and any combination thereof.

5. The method of claim 3 , wherein promoting the overall skin appearance comprises at least one of preventing the visible signs of aging and weathered skin including wrinkles and lines; evening of skin surface; reducing skin pore size or any combination thereof.

6. The method of claim 1 , wherein said method further comprises determining the maintenance and/or promotion of the skin structure, strength, cohesion or barrier function in comparison to a predetermined threshold value.

7. The method of claim 6 , wherein the predetermined threshold is a value measured before administering the composition to the skin.

8. The method of claim 6 , wherein the predetermined threshold is an average value obtained from individuals with healthy skin.

9. The method of claim 6 , wherein the predetermined threshold is an average value obtained from individuals with disturbed skin.

10. The method of claim 1 , wherein the polar solvent is selected from the group consisting of water, ethanol, propylene glycol, butylene glycol, methanol, glycerol, propanol, butanol, dipropylene glycol, pentylene glycol, hexylene glycol, dimethyl formamide, acetonitrile, dimethyl sulfoxide, dichloromethane, ethyl acetate, tetrahydrofuran, formic acid, acetic acid, acetone and any combination thereof.

11. The method of claim 10 , wherein the polar solvent is water.

12. The method of claim 10 , wherein the polar solvent is water and at least one of ethanol, propylene glycol, butylene glycol, methanol, glycerol and acetone.

13. The method of claim 1 , wherein the composition is a cosmetic or pharmaceutical composition further comprising a cosmetically or pharmaceutically acceptable diluent, carrier or excipient.

14. The method of claim 13 , wherein the cosmetic or pharmaceutical composition is formulated for topical application.

15. The method of claim 1 , wherein the composition further comprises at least one additional active ingredient.

16. The method of claim 1 , wherein the filtrate of step (e) is further filtrated through a filter having a pore size of less than 1.5μ.

17. The method of claim 1 , wherein the Jojoba plant part is selected from the group consisting of roots, stems, leaves, seeds, fruit or any combination thereof.

18. The method of claim 1 , wherein the Jojoba plant or part thereof is in a form selected from the group consisting of fresh, partially dried or completely dried.

19. The method of claim 1 , wherein the maintaining and/or promoting the skin structure, strength, cohesion or any combination thereof comprises activating at least one gene encoding a polypeptide involved in cell to cell adhesion and/or in keratinocyte differentiation.

20. The method of claim 19 , wherein the polypeptide involved in cell to cell adhesion is selected from the group consisting of desmoplakin I, desmoplakin II, syndecan 1, involucrin and fibronectin.

21. The method of claim 19 , wherein the polypeptide involved in keratinocyte differentiation is selected from the group consisting of cytokeratin 5, cytokeratin 2E/A, cytokeratin 1 and cytokeratin 10.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2024
From: FRUTAROM LTD.
To: LUCAS MEYER COSMETICS ISRAEL LTD.
Reel/Frame 067186/0789 →
MERGER Recorded Apr 16, 2024
From: I.B.R. -- ISRAELI BIOTECHNOLOGY RESEARCH LTD.
To: FRUTAROM LIMITED
Reel/Frame 067129/0288 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: KACHKO-CHERNETSKY, ILANA; HAVAS, FABIEN; BEN-CHITRIT, OLGA; VON OPPEN-BEZALEL, LEA; PERRY, INON; ALILUIKO, ALEX
To: IBR -- ISRAELI BIOTECHNOLOGY RESEARCH LTD.
Reel/Frame 033215/0174 →
Continuity (2)
Provisional Application 61564886 · Nov 30, 2011
Related Publication 20140308372A1 · Oct 16, 2014